Trial intelligence / Profile preview

Nanocurcumin and ubiquinone for migraine without aura

IRCT2017080135444N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Sep 2017
Modality
Small Molecules, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3 trial of nanocurcumin and coenzyme q10 in migraine, sponsored by Tehran University of Medical Sciences. Started Sep 2017; status: completed.

02

Drugs

nanocurcumincoenzyme q10
03

Conditions

migraine

Beyond the preview

Go deeper on IRCT2017080135444N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017080135444N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call